Peripheral Vascular Devices Market Trends and Forecast Report - Persistence Market Research

The peripheral vascular devices market is a rapidly expanding segment within the global healthcare industry. These devices are used in the treatment of peripheral arterial disease (PAD) and other vascular conditions that affect blood vessels outside the brain and heart. In particular, these devices aim to address the blockage of blood vessels in limbs, which can lead to severe complications such as tissue damage, amputations, and increased morbidity. With the increasing prevalence of vascular diseases worldwide, the demand for peripheral vascular devices is projected to see substantial growth in the coming years.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/33159

Overview of the Market

The global peripheral vascular devices market was valued at US$ 4.5 billion in 2021 and is expected to grow at a CAGR of 6.6%, reaching US$ 8.9 billion by 2032. This robust growth is primarily driven by the rising incidence of peripheral arterial disease (PAD), a condition characterized by the narrowing or blockage of peripheral arteries, and the increasing adoption of advanced interventional therapies. As Persistence Market Research indicates, the market for peripheral vascular devices is expected to expand significantly, driven by technological innovations in vascular stents, balloons, and other related devices.

In terms of market share, peripheral vascular stents are poised to dominate the market, accounting for US$ 6.6 billion by 2032. The sale of these devices represented 43.4% of the total stents market in 2021. Geographically, the North American region, especially the United States, holds a significant market share due to increased healthcare spending, awareness of PAD, and advancements in device technology. With a large portion of the population affected by PAD, the demand for peripheral vascular devices in the U.S. is set to maintain a high trajectory.

Key Highlights from the Report

• The global market for peripheral vascular devices was valued at US$ 4.5 billion in 2021 and is estimated to grow at a CAGR of 6.6%.
• Peripheral vascular stents are projected to account for US$ 6.6 billion of the market value by 2032.
• North America holds a dominant market share, with the U.S. accounting for nearly 94.5% of the regional market in 2021.
• The prevalence of peripheral arterial disease (PAD) is increasing globally, contributing significantly to market growth.
• Advances in drug-eluting and bioresorbable stent technologies are expected to drive innovation and demand in the market.
• Regulatory support and reimbursement policies are improving, boosting the accessibility of these devices in low- and middle-income economies.

Market Segmentation

The peripheral vascular devices market can be segmented into various categories, including product type, end-user, indication, and geographical region. The products in this market include vascular stents, balloons, and bioresorbable scaffolds, each designed for the treatment of vascular diseases. In terms of product type, peripheral vascular stents (including drug-eluting and balloon-expandable stents) are expected to account for the largest market share, representing 78.5% of the global market in 2021.

Regarding indications, peripheral arterial disease (PAD) holds the largest market share of 30.3%. PAD is a progressive condition that occurs when fatty plaque builds up in the arteries, narrowing them and restricting blood flow to the limbs. This growing prevalence of PAD is one of the major factors fueling demand for peripheral vascular devices. Additionally, end-users of these devices include hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization labs, with ASCs seeing increased adoption due to cost-effective outpatient treatments.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/peripheral-vascular-devices-market.asp

Regional Insights
North America

In 2021, North America accounted for the largest share of the global peripheral vascular devices market. The United States, in particular, contributed to 94.5% of the regional market. The high incidence of peripheral arterial disease (PAD), along with the presence of numerous leading medical device manufacturers, has made the U.S. a lucrative market for peripheral vascular devices. Moreover, favorable reimbursement policies, extensive healthcare infrastructure, and rapid adoption of innovative technologies, such as drug-eluting stents, are expected to continue driving market growth in North America.

Europe

Europe is also a significant market for peripheral vascular devices, with Germany leading the charge. In 2021, Germany held 22.3% of the European market share. The increasing focus on research and development (R&D), along with the high prevalence of peripheral arterial disease (PAD), contributes to the region's robust market position. Additionally, Germany's adoption of new healthcare technologies and its strong manufacturing capabilities in the medical device sector make it a key player in the European market.

Market Drivers

Several factors are contributing to the growth of the peripheral vascular devices market. The foremost driver is the increasing prevalence of peripheral arterial disease (PAD), which is particularly prevalent among the aging population. According to the National Library of Medicine (NLM), approximately 20% of adults over the age of 55 suffer from PAD, which is exacerbated by lifestyle factors such as smoking, poor diet, and physical inactivity.

In addition, the growing focus on interventional cardiology has led to a rise in angioplasty procedures, where devices like stents and balloons are commonly used. Moreover, technological advancements in device design and drug-eluting technologies are significantly improving patient outcomes and reducing the chances of restenosis (re-narrowing of the artery), thus increasing the demand for these devices.

Market Restraints

Despite its significant growth potential, the peripheral vascular devices market faces some challenges. One major restraint is the increasing risk of product recalls due to failures in deployment or adverse health events such as bleeding or strokes. For example, the FDA recalled Cook Medical's Zilver PTX drug-eluting peripheral stent in 2013 due to deployment issues. Similarly, in 2021, Boston Scientific recalled its Vici and Venovo venous stents, which affected market dynamics.

Additionally, the high cost of advanced vascular devices, especially in developing countries, limits accessibility and hampers market growth in low-income regions.

Market Opportunities

The market for peripheral vascular devices presents several growth opportunities. The rise in the number of endovascular interventions, coupled with an increase in the number of ambulatory surgical centers (ASCs), is expected to propel the market forward. Government initiatives and reimbursement policies aimed at making these devices more accessible in low and middle-income countries also offer significant growth prospects. Furthermore, technological innovations such as the development of bioresorbable stents and drug-coated balloons offer additional opportunities for market players to differentiate their product offerings.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/33159

Reasons to Buy the Report

• Gain insights into the market trends and forecast for the global peripheral vascular devices market from 2022 to 2032.
• Understand the competitive landscape and key strategies adopted by market players.
• Explore the market segmentation by product type, end-user, and region to better target potential opportunities.
• Learn about the market drivers, restraints, and opportunities shaping the growth of the peripheral vascular devices market.
• Understand the regional dynamics, including the dominant markets in North America, Europe, and East Asia.

Frequently Asked Questions (FAQs)

• How Big is the Peripheral Vascular Devices Market?
• Who are the Key Players in the Global Market for Peripheral Vascular Devices?
• What is the Projected Growth Rate of the Peripheral Vascular Devices Market?
• What is the Market Forecast for Peripheral Vascular Devices in 2032?
• Which Region is Estimated to Dominate the Peripheral Vascular Devices Industry through the Forecast Period?

Company Insights

Key players operating in the peripheral vascular devices market include:
• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical Inc.
• MicroPort Scientific Corporation (EndovastecTM)
• Medtronic Plc.
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Becton, Dickinson, and Company
• W. L. Gore & Associates Inc.

Recent Developments:

• In June 2021, Endovastec completed the first implantation of the Endovastec Minos Stent Graft System in Brazil, expanding the availability of innovative stent graft systems.
• In November 2020, Cook Medical Inc. announced that its Zilver® VenaTM venous self-expanding stent would be available in the U.S., further enhancing its market presence.

The peripheral vascular devices market continues to show substantial growth, driven by the increasing prevalence of vascular diseases, technological innovations, and rising demand for interventional procedures. As a key part of the global healthcare infrastructure, this market is set to continue its upward trajectory, offering significant opportunities for both established and emerging players.

Read More Related Reports:

Reusable Incontinence Products Market https://www.persistencemarketresearch.com/market-research/reusable-incontinence-products-market.asp Healthcare
Lensometer Market https://www.persistencemarketresearch.com/market-research/lensometer-market.asp Healthcare
Macular Degeneration Treatment Market https://www.persistencemarketresearch.com/market-research/macular-degeneration-treatment-market.asp Healthcare
Body Contouring Devices Market https://www.persistencemarketresearch.com/market-research/body-contouring-devices-market.asp Healthcare
Cell Counting Market https://www.persistencemarketresearch.com/market-research/cell-counting-market.asp Healthcare

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.